Over 75% of patients have accessed care virtually as of 2024 – the primary reasons being for improved convenience and choice. As patient expectations for digital care continue to rise, the direct-to-consumer (DTC) movement should be top of mind for pharma manufacturers. Watch this webinar with seasoned leaders from Sun Pharmaceuticals and Phil to unpack the evolving landscape of digital care from the perspective of patients and providers, and its potential to improve prescription access, adherence and affordability.
Key trends in the digital care landscape and the expected impact on patient outcomes, provider engagement, and brand performance
Analyzing the efficacy of DTC on patient outcomes across therapeutic areas
Strategies for developing a DTC model that meets patient needs for greater convenience, choice and transparency across their healthcare journey
How pharmaceutical manufacturers are introducing successful DTC programs
Discover the building blocks of a seamless digital care experience that delights patients and providers. Book a demo of the PhilRx Digital Hub.